encorafenib,binimetinib,cetuximab,irinotecan
pfizer,ono pharmacueticals,pierre fabre,eli lilly
 presenting beacon crc post hoc analysis: conclusions
az 2022 
MD-PhD
Passionate Oncologist
Focus on Molecular Oncology 
Focus on Gastrointestinal Oncology